TELA Bio, Inc. (NASDAQ:TELA) Q4 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the TELA Bio Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Tela Bio Inc. (TELA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 3,679,726 | $11,112,773 | +93% | 0.47% |
| 2. | SilverArc Capital Devesh Gandhi | 3,065,649 | $9,258,260 | +173% | 2.02% |
| 3. | AIGH Investment Partners Orin Hirschman | 2,662,785 | $8,041,611 | +8% | 2.51% |
| 4. | Stonepine Capital Timothy P. Lynch | 2,353,099 | $7,106,359 | +112% | 5.73% |
| 5. | DAFNA Capital Management Nathan Fischel | 1,441,029 | $4,351,908 | 1.1% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.25 | 64,444 | Officer | 155,388 | 2024-10-24 | Filing | |
| $2.25 | 22,222 | Officer | 91,082 | 2024-10-24 | Filing | |
| $2.25 | 88,888 | Officer, Director | 458,897 | 2024-10-24 | Filing | |
| $2.25 | 6,666 | Officer | 57,279 | 2024-10-24 | Filing | |
| $8.01 | 5,000 | 3,610,709 | 2022-07-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.54 | 36,600 | Large Shareholder | 2,407,242 | 2024-07-02 | Filing | |
| $4.68 | 13,700 | Large Shareholder | 2,443,842 | 2024-07-01 | Filing | |
| $4.74 | 378,000 | Large Shareholder | 2,457,542 | 2024-06-28 | Filing | |
| $9.41 | 27,700 | Large Shareholder | 2,835,542 | 2023-04-21 | Filing | |
| $9.43 | 28,300 | Large Shareholder | 2,863,242 | 2023-04-20 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 12,769 | $16 | 0% | |
| 2. | 0 | $0 | 0% |
News See All
TELA Bio, Inc. (NASDAQ:TELA) Q3 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the TELA Bio Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
TELA Bio, Inc. (NASDAQ:TELA) Q2 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the TELA Bio Second Quarter 2024 Earnings Conference Call. [Operator Instructions].
TELA Bio, Inc. (NASDAQ:TELA) Q1 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the TELA Bio First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
TELA Bio, Inc. (NASDAQ:TELA) Q4 2023 Earnings Call Transcript
TELA Bio, Inc. misses on earnings expectations. Reported EPS is $-0.53 EPS, expectations were $-0.44.
5 Oversold Healthcare Stocks To Buy Right Now
In this article, we will be taking a look at 5 oversold healthcare stocks to buy right now.
TELA Bio, Inc. (NASDAQ:TELA) Q3 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by, and welcome to the TELA Bio Third Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.
TELA Bio, Inc. (NASDAQ:TELA) Q2 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the TELA Bio Second Quarter 2023 Earnings Conference Call. At this time all participants are in a listen-only mode.
TELA Bio, Inc. (NASDAQ:TELA) Q1 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the TELA Bio First Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
TELA Bio, Inc. (NASDAQ:TELA) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the TELA Bio Fourth Quarter and Full Year 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Billionaire Hedge Funds
